Latest Reimbursement News

Critica Limited has produced its first commercial-quality Mixed Rare Earth Carbonate at 58% TREO, confirming a refinery-aligned product pathway, while launching a major resource upgrade drilling program at its Jupiter Rare Earths Project in Western Australia.

Galileo Mining maintains a strong cash position of approximately A$8.2 million as it confirms extensive PGE-nickel-copper mineralisation at Norseman's Mission Sill and completes deep diamond drilling beneath the Callisto deposit.

Lindian Resources has locked in a US$11.6 million financing package from Malawi's NBS Bank, bolstering the Kangankunde Rare Earths Project with asset-backed and working capital facilities. This deal complements Lindian’s recent A$100 million placement and underscores its commitment to local partnerships.

4DMedical lands a contract with pharma giant GSK, gains UKCA certification for its CT:VQ™ lung imaging technology, and joins the S&P/ASX 200, marking a significant step in its global expansion.

Emyria has unveiled the Empax Global Partnership Program, a high-margin clinical delivery platform targeting international drug sponsors amid growing demand for psychedelic-assisted mental health treatments.

Worley Limited reveals the ongoing Middle East conflict is causing significant project delays and an estimated $30 to $40 million hit to FY26 underlying EBITA, prompting a revision to its growth outlook.

Channel Infrastructure has locked in a government contract for 93 million litres of additional diesel storage at Marsden Point, adding about $8 million revenue in 2026 and reinforcing its role in New Zealand’s fuel security.

PainChek has secured a landmark agreement with Sabra Health Care REIT to deploy its AI-powered pain assessment across up to 20,000 beds in North America, marking a pivotal step in its US expansion.

Diatreme Resources is consolidating its Far North Queensland silica assets by selling the Cape Flattery Silica Project to its joint venture with Sibelco, securing $7.4 million in fresh capital and streamlining project ownership ahead of key development milestones.

Pacific Edge reported a 2.7% increase in test volumes for Q4 2026 despite operational challenges, supported by growing momentum toward Medicare coverage and expanded commercial payer adoption in the US and Asia Pacific.

EBR Systems has reported a significant increase in commercial implantations of its WiSE System in Q1 2026, more than doubling case volumes from the previous quarter and projecting preliminary revenue between US$2.25 million and US$2.36 million.

Imricor Medical Systems has submitted its NorthStar Mapping System for FDA pediatric label expansion, aiming to accelerate adoption in over 250 US children’s hospitals and broaden its commercial footprint.